Boothbay Fund Management’s STAAR Surgical STAA Stock Holding History

Boothbay Fund Management’s Portfolio STAA Stock Details STAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-15,000	Closed	-$714K	–	1922
2024 Q2	$714K	Buy	+15,000	New	+$657K	0.02%	866

Other funds holding STAA

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Yunqi Capital Hong Kong $92.4M AUM 16.3% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Boothbay Fund Management's STAA Position: Q4 2025 in Review

Boothbay Fund Management sold out of STAAR Surgical (STAA) in Q4 2025, closing a stake of 25,668 shares — an estimated $690K sold.

Boothbay Fund Management first reported a position in STAA in Q1 2020 and held it in 4 quarters. The position peaked at $952K in Q2 2024. 201 funds tracked by Wall St. Rank hold STAA as of Q4 2025.

Boothbay Fund Management reported no remaining STAAR Surgical position as of Q4 2025 after selling out during the quarter.
Boothbay Fund Management sold 25,668 STAAR Surgical shares in Q4 2025, an estimated $690K.
Boothbay Fund Management first reported a position in STAAR Surgical in Q1 2020 and held it in 4 quarters.
Boothbay Fund Management's STAAR Surgical position peaked at $952K in Q2 2024.
201 funds tracked by Wall St. Rank held STAAR Surgical as of Q4 2025.

Based on Boothbay Fund Management's 13F filing for Q4 2025, filed 17 Feb 2026.